CAM-ICU Diagnosed Delirium Clinical Trial
Official title:
Monocenter, Double Blind, Randomised, Placebo Controlled Study to Evaluate Physostigmine for the Treatment of Delirium in Perioperative Intensive Care Medicine
Evaluation if physostigmine reduces symptoms in patients who has developed a delirium in Intensive care after a surgery
n/a